Skip to main content
. Author manuscript; available in PMC: 2013 Mar 24.
Published in final edited form as: Obstet Gynecol. 2011 Mar;117(3):551–557. doi: 10.1097/AOG.0b013e31820afc46

Table 1.

Characteristics of users by source of OCPs

Characteristics Prescription (n =
474)
OTC (n =
466)
P-Value
Age, No. (%)
18-24 years 157 (33.1) 100 (21.5)
25-34 years 210 (44.3) 200 (42.9) [lt].001
35-44 years 107 (22.6) 166 (35.6)
Parity, No. (%)
0 live births 86 (18.1) 55 (11.8)
1 live birth 79 (16.7) 78 (16.8) .02
2 or more live births 309 (65.2) 332 (71.4)
Marital Status, No. (%)
Married/Cohabiting 300 (63.3) 320 (68.7) .08
Single 174 (36.7) 146 (31.3)
Nativity/Education, No. (%)
US-born 177 (37.3) 97 (20.8)
Mexican-born, US-educated 163 (34.4) 167 (35.8) [lt].001
Mexican-born and educated 134 (28.3) 202 (43.4)
Border crossing frequency. No. (%)
Never/almost never 239 (50.4) 132 (28.3)
Less than once per month 77 (16.2) 51 (10.9) [lt].001
1-3 times per month 101 (21.3) 162 (34.8)
Once per week or more 57 (12.0) 121 (26.0)
Receives US government assistance, No. (%) 363 (76.6) 334 (71.7) .09
Has US health insurance, No. (%) 113 (23.8) 51 (10.9) [lt].001
Duration of OCP use prior to study, No. (%)
Short duration (less than 200 days) 150 (31.7) 107 (23.0)
Medium duration (200-1500 days) 210 (44.3) 221 (47.4) .01
Long duration (greater than 1500 days) 114 (24.1) 138 (29.6)
Side effects related to OCP use, No. (%)
Did not report side effects 330 (69.6) 362 (77.7)
Reported side effects 144 (30.4) 104 (22.3) .01
Planned OCP use, No. (%)
3 months or less 9 (1.9) 18 (3.9)
4-12 months 22 (4.6) 29 (6.2) .05
Between 1 and 2 years 103 (21.7) 125 (26.8)
Two years or more 267 (56.3) 229 (49.1)
Don’t know/Not sure 73 (15.4) 65 (14.0)